Tag: Antivenoms
CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion
CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing.
Featured Article
Reducing downtime through real-time shop floor insights with Minitab’s Prolink
Unplanned downtime remains one of the most costly – and often misunderstood – challenges on the manufacturing floor.
